CCKA and CCKB Receptors Are Expressed in Small Cell Lung Cancer Lines and Mediate Ca2+ Mobilization and Clonal Growth

Cancer Research

Volumn 53, Issue 21, 1993, Pages 5208-5213

  Sethi, Tariq ^a   Herget, Thomas ^a   Wu, S Vincent ^b   Walsh, John H ^b   Rozengurt, Enrique ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CALCIUM; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; GASTRIN; MESSENGER RNA; PRIMER DNA; RNA; CALCIUM ION; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CLONE; CELL CULTURE; COMPARATIVE STUDY; DOG; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KINETICS; LUNG TUMOR; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MURIDAE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; RAT; SEQUENCE HOMOLOGY; SMALL CELL CARCINOMA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CLONOGENIC ASSAY; DOSE RESPONSE; GASTRIN BLOOD LEVEL; GENE AMPLIFICATION; HUMAN CELL; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BLOTTING, NORTHERN; BRADYKININ; CALCIUM; CARCINOMA, SMALL CELL; CLONE CELLS; COMPARATIVE STUDY; DNA PRIMERS; DOGS; GASTRINS; GENE EXPRESSION; HUMAN; KINETICS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MURIDAE; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, CHOLECYSTOKININ; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE HOMOLOGY, AMINO ACID; SINCALIDE; TUMOR CELLS, CULTURED;

EID: 0027340221     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Smyth, J. F., Fowlie, S. M., Gregor, A., Crompton, G. K., Busuttil, A., Leonard, R. C. and Grant, I. W. The impact of chemotherapy on small cell carcinoma of the bronchus. Quant. J. Med., 61: 969-973, 1986.
2. 2+ in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem. Biophys. Res. Commun., 164: 66-73, 1989.
3. Bunn, P. A., Dienhart, D. G., Chan, D., Puck, T. T., Tagawa, M., Jewett, P. B. and Braunschweiger, E. Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc. Natl. Acad. Sci. USA, 87:2162-2166, 1990.
4. Sethi, T. and Rozengurt, E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin and neurotensin. Cancer Res., 57: 3621-3623, 1991.
5. Sethi, T., Langdon, S., Smyth, J. and Rozengurt, E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res., 52: 2737s-2742s, 1992.
6. Rozengurt, E. Early signals in the mitogenic response. Science (Washington DC), 234: 161-166, 1986.
7. Rozengurt, E. Neuropeptides as cellular growth factors. Eur. J. Gin. Invest., 21: 123-134, 1991.
8. 2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res., 52: 6031-6035, 1992.
9. Yoder, D. G. and Moody, T. W. High affinity binding of cholecystokinin to small cell lung cancer cells. Peptide. (New York), 8: 103-107, 1987.
10. Lin, S. W., Holladay, M. W., Barrett, R. W., Wolfram, C. A., Miller, T. R., Witte, D., Kerwin, J. F., Wagenaar, F. and Nadzan, A. M. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Mol. Pharmacol., 36: 881-886, 1989.
11. Jensen, R. T., Wank, S. A., Rowley, W. H., Sato, S. and Gardner, J. D. Interaction of CCK with pancreatic acinar cells. Trends Pharmacol. Sci., 10: 418-423, 1989.
12. Lotti, V. J. and Chang, R. L. A new potent and selective nonpeptide gastrin antagonist and brain cholecystokinin receptor ligand 365,260. Eur. J. Pharmacol., 162: 273-280, 1984.
13. Bock, M. G., DiPardo, R. M., Evans, B. E., Rittle, K. E., Whitter, W. L., Veber, D. E., Anderson, P. S. and Freidinger, R. M. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J. Med. Chem., 32: 13-16, 1989.
14. Staley, J., Jensen, R. T. and Moody, T. W. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells. Peptides (New York), 11:1033-1036, 1990.
15. Pisegna, J. R., deWeerth, A., Huppi, K. and Wank, S. A. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, function, expression and chromosomal localization. Biochem. Biophys. Res. Commun., 189: 296-303, 1992.
16. Kopin, A. S., Lee, Y.-M. McBride, E. W., Miller, L. J., Lu, M., Lin, H., Kalowski, L. F. and Beinborn, M. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA, 89: 3605-3609, 1992.
17. Wank, S. A., Pisegna, J. R. and deWeerth, A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc. Natl. Acad. Sci. USA, 89: 8691-8695, 1992.
18. Nakata, H., Matsui, T., Ito, M., Taniguchi, T., Naribayashi, Y. Nakamura, A., Kinoshikazu, K., Chihara, K., Hosoda, S. and Chiba, T. Cloning and characterization of gastrin receptor from ECL carcinoid tumor of Mastomys natalensis. Biochem. Biophys. Res. Commun., 187: 1151-1157, 1992.
19. Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Sanger, F., Nicklen, S. and Coulson, A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
21. Chirgwin, J. N., Przybyla, A. E., MacDonald, R. J. and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
22. Feinberg, A. P. and Vogelstein, B. A technique for radiolabeling DNA restriction fragments of high specific activity. Anal. Biochem., 132: 6-13, 1983.
23. Herget, T., Brooks, S. F., Broad, S. and Rozengurt, E. Relationship between the major protein kinase C substrates acidic 80-kDa protein-kinase-C substrate (80K) and myristoylated alanine-rich C-kinase substrate (MARCKS) Eur. J. Biochem., 209: 7-14, 1992.
24. Johnson, B. E. Whang-Peng, J., Naylor, S. L., Zbar, B., Brauch, H., Lee, E., Simmons, A., Russell, E., Nam, M. H. and Gazdar, A. F. Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J. Natl. Cancer Inst., 81: 1223-1228, 1989.
25. Berendsen, H. H. de Leij, L. de Vries, E. G. E., Mesander, G., Mulder, N. H. de Jong, B., Buys, C. H. C. M., Postmus, P. E., Poppema, S., Sluiter, H. J. and The, H. T. Characterization of three small cell lines established from one patient during longitudinal follow-up. Cancer Res., 48: 6891-6899, 1988.
26. Damstrup, L., Rygaard, K. Spang-Thomsen, M. and Poulsen, H. S. Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines. Cancer Res., 52: 3089-3093, 1992.
27. Simms, E., Gazdar, A. F., Abrams, P. G. and Minna, J. D. Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res., 40: 4356-4363, 1980.
28. 2+ mobilization, inositol phosphate accumulation and clonal growth in small cell lung cancer cells. Cancer Res., 51: 1674-1679, 1991.
29. Higginbottom, M., Horwell, D. C. and Roberts, E. Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single strucural class. Bio. Med. Chem. Lett., 3: 881-884, 1993.
30. Boden, P., Higginbottom, M., Hill, D. R., Horwell, D. C., Hughes, J., Rees, D. C., Roberts, E., Singh, L. Suman-chauhan, N. and Woodruff, G. N. Cholecystokinin dipeptoid antagonists: synthesis and anxiolytic profile of some novel CCK-A and CCK-B selective and “mixed” CCK-A/CCK-B antagonists. J. Med Chem., 36: 552-565, 1993.
31. Carney, D. N., Gazdar, A. F. and Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung. Cancer Res., 40: 1820-1823, 1980.
32. Corjay, M. H., Dorbranski, D. J., Way, J. M., Vlallet, J., Shapira, H., Worland, P., Sausville, E. A. and Battey, J. F. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J. Biol. Chem., 266: 18771- 18779, 1991.
33. Moody, T. W., Staley, J., Zia, F., Coy, D. H. and Jensen, R. T. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small cell lung cancer cell lines. J. Pharmacol. Exp. Ther., 263: 311-317, 1992.
34. Douglas, B. R., Woutersen, R. A., Jansen, J. B., Rovati, L. C. and Lamers, C. B. Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hampsters. Eur. J. Pharmacol., 161: 209-214, 1989.
35. Lamers, C. B. and Jansen, J. B. Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract. Eur. J. Cancer Clin. Oncol., 24: 267-273, 1988.
36. Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A. and Minna, J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (Lond.), 316: 823-826, 1985.
37. Goedert, M., Reeve, J. G., Emson, P. C. and Bleehen, N. M. Neurotensin in human small cell lung carcinoma. Br. J. Cancer, 50: 179-183, 1984.
38. Sausville, E., Carney, D. and Battey, J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J. Biol. Chem., 260: 10236-10241, 1985.
39. Rehfeld, J. F., Bardrum, L. and Hilsted, L. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res., 49: 2840-2843, 1989.
40. Geijer, T., Folkesson, R., Rehfeld, J. F. and Monstein, H. J. Expression of the cholecystokinin gene in a human (small-cell) lung carcinoma cell-line. FEBS Lett., 270: 30-32, 1990.
41. Woll, P. J. and Rozengurt, E. A neuropeptide antagonist that inhibits the growth of human small cell lung cancer cells in vitro. Cancer Res., 51: 1674-1679, 1991.
42. Langdon, S., Sethi, T., Ritchie, A., Muir, M., Smyth, J. and Rozengurt, E. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res., 52: 4554-4557, 1992.